Trademark applications and grants for Amylin Pharmaceuticals Inc. Amylin Pharmaceuticals Inc has 98 trademark applications. The latest application filed is for "BYDUREON ZYSP"
Patent Application | Date |
---|---|
HYPODERMIC NEEDLE ASSEMBLY HAVING A TRANSITION HUB FOR ENHANCING FLUID DYNAMICS AND MICROSPHERE INJECTABILITY 20130096531 - 13/520965 Estepa; Phillip A. ;   et al. | 2013-04-18 |
TREATMENT OF DIABETIC CARDIOMYOPATHY WITH A GLP-1 PEPTIDE 20120302501 - 12/945702 COOLIDGE; THOMAS R. ;   et al. | 2012-11-29 |
MIXING TOOL 20120296309 - 13/407518 Smith; Christine ;   et al. | 2012-11-22 |
GLP-1 RECEPTOR AGONISTS TO TREAT PANCREATITIS 20120295850 - 13/567932 Tatarkiewicz; Krystyna ;   et al. | 2012-11-22 |
HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES 20120253023 - 13/323608 LEVY; Odile Esther ;   et al. | 2012-10-04 |
NCAGE Code | 39FP8 | AMYLIN PHARMACEUTICALS INC |
CAGE Code | 39FP8 | AMYLIN PHARMACEUTICALS INC |
SEC | 0000881464 | AMYLIN PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.